Home › Osteoporosis › NCT05845021
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
The Impact of a Surgeon-Initiated Bone Health Referral Pathway on Implant-Related Complications in Patients With Osteoporosis Undergoing Lower Extremity Arthroplasty
Who can join
Ages 50 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * \>50 * DEXA-confirmed diagnosis of osteoporosis Exclusion Criteria: * Prior diagnosis of osteoporosis * Prior treatment for osteoporosis
About the study
The goal of this clinical trial is to observe the impact of a surgeon-driven bone health referral pathway following lower extremity arthroplasty. The main question this study aims to answer is:
1\) What is impact of a surgeon-driven bone health referral pathway on implant-related complications and fragility fractures when compared to standard of care primary care provider referral.
Researchers will compare the endocrinology referral pathway and standard of care to see if there is a difference in treatment rates, fragility fractures, and implant-related complications following lower extremity arthroplasty.
What is being tested
- Surgeon-Initiated Bone Health Referral Pathway (combination product)
Sponsor: Johns Hopkins University · Participants: 2,000 · Started: Sep 27, 2023
Contact the study team
- Savyasachi C Thakkar, MD · Phone: 443-997-2663
Official record on ClinicalTrials.gov — NCT05845021
Locations in the U.S.
| Maryland | Charter Professional Center, Columbia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.